glp-1 microbiome and GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk GLP-1 Microbiome+ | Digestive Support
Description
The medication and alternative therapy use among participants also decreased significantly, suggesting that GLP-1 medications may reduce the need for additional symptom management strategies
Final Verdict Maximus Tribe scores 54/100
Consistent with our previous findings (20), oral gavage of systemically active doses of sitagliptin (10 mg/kg) inhibited plasma DPP-4 activity by approximately 85% when assessed 30 minutes after oral administration (Figure 1B)
doi: 10.1016/j.npep.2020.102018
Akkermansia muciniphila Prebiotics and postbiotics
Sasaki-Hamada, S
